secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0000950170-22-011501
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics shareholders elect three Class II directors, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- All three director nominees (Fishman, Ho, Walsh) elected with ~39.5M votes each.
- Deloitte & Touche ratified as auditor for FY2022 with 51.8M for, 3.1M against.
- Advisory vote on executive compensation approved with 36.9M for, 5.7M against.
- Shareholders selected every year as the frequency of say-on-pay votes; board adopts annual policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000095017022011501/0000950170-22-011501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000095017022011501/beam-20220608.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer